TrialActa dermato-venereologica2024

Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Study.

Lina Renkhold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.